As Labor Day fades into memory and children return to classrooms, the air is filled with the familiar scent of pumpkin spice, signaling the start of fall. Along with the changing seasons comes the annual reminder to prepare for respiratory virus season, a time when vaccines play a crucial role in protecting public health. This year, however, the landscape is a bit different. Robert F. Kennedy Jr., an anti-vaccine activist, has taken on the role of the United States' top health official. His influence has raised concerns about the potential challenges in rolling out this year's vaccines. For instance, one of his early actions as health secretary was to cancel a public advertising campaign promoting flu shots during a particularly severe flu season last year. Now, the Centers for Disease Control and Prevention (CDC) vaccine advisory committee—responsible for setting vaccination recommendations and determining insurance coverage—has been unable to function effectively. A federal judge ruled in March that the members Kennedy appointed to the panel were not legally qualified, and their policy changes have been temporarily invalidated. Despite these obstacles, the fall vaccine rollout appears to be on track and may even be relatively uneventful. The Food and Drug Administration (FDA) has approved updated flu and COVID-19 vaccines for the current season, and these shots are already arriving at pharmacies. Many people have likely received multiple reminders from their local pharmacies, which have been actively preparing for the vaccine distribution. While there are still some access challenges, the process seems similar to last year's efforts. Kennedy’s attempts to downplay the severity of this year’s measles outbreak have also drawn attention. Last week, he tried to obscure the number of infant deaths from measles, which stood at two, including a newborn. Despite these issues, the overall vaccine distribution appears to be proceeding without major disruptions, offering a sense of normalcy amid the ongoing challenges in public health leadership.